Annual report
4480.TEDINET S100XUX3
Period2025-01-01 → 2025-12-31
Filed2026-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 151
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥36.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥20.5bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.2bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.8bn | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥743m | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.1bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥975m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥563m | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥975m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥41.3bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥45.2bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥25.4bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥21.8bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.2bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.5bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥25.0bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.8bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥17.6bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥15.2bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥14.0bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥19.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.4bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥14.0bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.5bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.9bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.1bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥751m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥6.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥11.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥927m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥30.62 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.17 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.53 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.77 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.47 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.62 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.55 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.16 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥17.15 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥478.95 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥621.43 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥542.49 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥469.79 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥438.43 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 35.9% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.0% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.6% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.8% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,815 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 1,487 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 1,105 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 895 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 719 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥29.6bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥20.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥16.4bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.6bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.7bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥2.7bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥3.1bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.6bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.9bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥770m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥333m | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.1bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | −¥1.5bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥3.1bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥2.7bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥653m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥40.5bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥40.8bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥23.9bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.5bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.8bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥25.2bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥19.6bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥15.3bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥21.3bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥18.1bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥15.4bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥14.1bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥14.2bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-47.8 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.35 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.95 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.48 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.64 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥93.75 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.9 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥36.75 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.9 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥495.25 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥653.79 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥557.89 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥479.42 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥441.63 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 37.8% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.1% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.6% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.4% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 32,738,600 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,738,600 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,738,600 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,706,800 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,462,500 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,511 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 1,042 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 822 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 699 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 589 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 69
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥147m |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥92m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-12-31 | −¥2m |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥17.9bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥5.7bn |
| Medical Platform Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥8.0bn |
| Medical Platform Businessreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥354m |
| Medical Platform Businessreportable segment | employees | at 2025-12-31 | 655 pure |
| Medical Platform Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥9.4bn |
| Medical Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥9.4bn |
| Medical Platform Businessreportable segment | segment assets | at 2025-12-31 | ¥12.3bn |
| Medical Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥454m |
| New Development Servicesreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥1.3bn |
| New Development Servicesreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥50m |
| New Development Servicesreportable segment | employees | at 2025-12-31 | 212 pure |
| New Development Servicesreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥1.1bn |
| New Development Servicesreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥1.1bn |
| New Development Servicesreportable segment | segment assets | at 2025-12-31 | ¥1.2bn |
| New Development Servicesreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥769m |
| Recruitment Platform Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥1m |
| Recruitment Platform Businessreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥604m |
| Recruitment Platform Businessreportable segment | employees | at 2025-12-31 | 685 pure |
| Recruitment Platform Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥26.3bn |
| Recruitment Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥26.3bn |
| Recruitment Platform Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥2m |
| Recruitment Platform Businessreportable segment | segment assets | at 2025-12-31 | ¥9.9bn |
| Recruitment Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥9.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-01-01 → 2025-12-31 | ¥9.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-01-01 → 2025-12-31 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-12-31 | ¥36.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-12-31 | ¥36.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-12-31 | ¥23.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-12-31 | ¥7.9bn |
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥55m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥109m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥4m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥27.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥5.0bn |
| Medical Platform Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥1.9bn |
| Medical Platform Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥230m |
| Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥7.6bn |
| Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥7.6bn |
| Medical Platform Businessreportable segment | segment assets | at 2024-12-31 | ¥6.3bn |
| Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥15m |
| New Development Servicesreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥16m |
| New Development Servicesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥610m |
| New Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥610m |
| New Development Servicesreportable segment | segment assets | at 2024-12-31 | ¥58m |
| New Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥377m |
| Recruitment Platform Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥11.2bn |
| Recruitment Platform Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥546m |
| Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥21.1bn |
| Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥21.1bn |
| Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥4m |
| Recruitment Platform Businessreportable segment | segment assets | at 2024-12-31 | ¥10.9bn |
| Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-01-01 → 2024-12-31 | ¥13.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-01-01 → 2024-12-31 | ¥794m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-12-31 | ¥29.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-12-31 | ¥29.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-12-31 | ¥17.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-12-31 | ¥7.3bn |
| Medical Platform Businessreportable segment | employees | at 2025-12-31 | 535 pure |
| New Development Servicesreportable segment | employees | at 2025-12-31 | 68 pure |
| Recruitment Platform Businessreportable segment | employees | at 2025-12-31 | 675 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,455
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | CurrentYearInstant | 697000000 | JPY |
| Current liabilities | Prior1YearInstant | 10562000000 | JPY |
| Current liabilities | CurrentYearInstant | 11516000000 | JPY |
| Long term loans payable | Prior1YearInstant | 11564000000 | JPY |
| Long term loans payable | CurrentYearInstant | 12299000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 2629000000 | JPY |
| Deferred tax liabilities | CurrentYearInstant | 2563000000 | JPY |
| Other ncl | Prior1YearInstant | 224000000 | JPY |
| Other ncl | CurrentYearInstant | 74000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 14418000000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 14937000000 | JPY |
| Liabilities | Prior1YearInstant | 24981000000 | JPY |
| Liabilities | CurrentYearInstant | 26453000000 | JPY |
| Capital stock | Prior1YearInstant | 47000000 | JPY |
| Capital stock | CurrentYearInstant | 47000000 | JPY |
| Capital surplus | Prior1YearInstant | 14196000000 | JPY |
| Capital surplus | CurrentYearInstant | 12217000000 | JPY |
| Retained earnings | Prior1YearInstant | 6601000000 | JPY |
| Retained earnings | CurrentYearInstant | 7576000000 | JPY |
| Treasury stock | Prior1YearInstant | -621000000 | JPY |
| Treasury stock | CurrentYearInstant | -4843000000 | JPY |
| Shareholders equity | Prior1YearInstant | 20223000000 | JPY |
| Shareholders equity | CurrentYearInstant | 14998000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -40000000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | -224000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 25000000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 26000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -14000000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | -198000000 | JPY |
| Non controlling interests | Prior1YearInstant | 10000000 | JPY |
| Non controlling interests | CurrentYearInstant | － | JPY |
| Net assets | Prior1YearInstant | 20219000000 | JPY |
| Net assets | CurrentYearInstant | 14799000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 45201000000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 41252000000 | JPY |
| Net sales | Prior1YearDuration | 29302000000 | JPY |
| Net sales | CurrentYearDuration | 36786000000 | JPY |
| Cost of sales | Prior1YearDuration | 10382000000 | JPY |
| Cost of sales | CurrentYearDuration | 13600000000 | JPY |
| Gross profit | Prior1YearDuration | 18919000000 | JPY |
| Gross profit | CurrentYearDuration | 23186000000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 16592000000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 21036000000 | JPY |
| Operating income | Prior1YearDuration | 2326000000 | JPY |
| Operating income | CurrentYearDuration | 2150000000 | JPY |
| Interest income noi | Prior1YearDuration | 2000000 | JPY |
| Interest income noi | CurrentYearDuration | 22000000 | JPY |
| Settlement received noi | Prior1YearDuration | 2234000000 | JPY |
| Settlement received noi | CurrentYearDuration | 372000000 | JPY |
| Subsidy income noi bounty | Prior1YearDuration | 13000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |